Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

48
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
48
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

242
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
242
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

68
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
68
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

337
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
337

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project.

Journal of thrombosis and thrombolysis·2025
Same author

Interdisciplinary sport injury research and the integration of qualitative and quantitative data.

BMC medical research methodology·2023
Same author

Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.

The Journal of antimicrobial chemotherapy·2023
Same author

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic.

Frontiers in pharmacology·2022
Same author

Determinants of mortality in cancer patients with unscheduled admission to the Intensive Care Unit: A prospective multicenter study.

Medicina intensiva·2022
Same author

Erratic enteric absorption of dolutegravir in a critically ill patient.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022

Related Experiment Video

Updated: Mar 8, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.4K

Computerized pharmacy surveillance and alert system for drug-related problems.

O Ferrández1,2, O Urbina1, S Grau1,3

  • 1Services of Hospital Pharmacy, Hospital Universitari del Mar, Barcelona, Spain.

Journal of Clinical Pharmacy and Therapeutics
|January 13, 2017
PubMed
Summary

A pharmacy warning system (PWS) integrated into electronic medical records effectively detects drug-related problems (DRPs), enhancing inpatient safety. This system identified most potential DRPs, proving superior to other available tools.

Keywords:
alertscomputerized prescriber order entrydrug-related problempharmacy warning systemprescription review

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K

Related Experiment Videos

Last Updated: Mar 8, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K

Area of Science:

  • * Clinical Informatics
  • * Pharmaceutical Sciences
  • * Patient Safety

Background:

  • * Drug-related problems (DRPs) significantly contribute to morbidity and mortality.
  • * Computerized strategies are needed to enhance drug safety.
  • * Existing clinical decision support systems for drug monitoring have limitations in scope and alert types.

Purpose of the Study:

  • * To describe the implementation of a pharmacy warning system (PWS) integrated within an electronic medical record (EMR).
  • * To assess the PWS's ability to detect potential DRPs during routine inpatient drug therapy validation.

Main Methods:

  • * Development of a PWS incorporating demographic data, drug dosage, laboratory results, and drug combination information (interactions, duplications).
  • * Application of the PWS in prescription reviews for hospitalized patients in 2012.
  • * Information from 83% of the hospital's pharmacopeia was entered into the PWS.

Main Results:

  • * The PWS detected 2808 potential DRPs, representing 79.1% of all DRPs identified during the study period.
  • * Twenty percent of detected DRPs were clinically relevant and required pharmacist intervention.
  • * The system demonstrated a high detection rate for potential DRPs.

Conclusions:

  • * The implemented PWS significantly enhances inpatient safety by detecting a majority of potential DRPs.
  • * The PWS exhibits a superior detection capability compared to other tools previously reported in the literature.
  • * Integration of PWS into EMR systems is a valuable strategy for improving drug safety.